{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:26:21Z","timestamp":1761060381405},"reference-count":105,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1253\/circj.cj-17-0550","type":"journal-article","created":{"date-parts":[[2017,7,5]],"date-time":"2017-07-05T22:06:40Z","timestamp":1499292400000},"page":"1075-1084","source":"Crossref","is-referenced-by-count":11,"title":["Prognostic Value of Chronic Kidney Disease Measures in Patients With Cardiac Disease"],"prefix":"10.1253","volume":"81","author":[{"given":"Yejin","family":"Mok","sequence":"first","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and Welch Center for Prevention, Epidemiology, and Clinical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoshana H.","family":"Ballew","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and Welch Center for Prevention, Epidemiology, and Clinical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health and Welch Center for Prevention, Epidemiology, and Clinical Research"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Levin A, Stevens PE. Summary of KDIGO 2012 CKD Guideline: Behind the scenes, need for guidance, and a framework for moving forward. <i>Kidney Int<\/i> 2014; 85: 49\u201361.","DOI":"10.1038\/ki.2013.444"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Kottgen A, Levey AS, et al. Evolving importance of kidney disease: From subspecialty to global health burden. <i>Lancet<\/i> 2013; 382: 158\u2013169.","DOI":"10.1016\/S0140-6736(13)60439-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Chronic Kidney Disease Prognosis Consortium; Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. <i>Lancet<\/i> 2010; 375: 2073\u20132081.","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. van der Velde M, Matsushita K, Coresh J, Astor BC, Woodward M, Levey A, et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality: A collaborative meta-analysis of high-risk population cohorts. <i>Kidney Int<\/i> 2011; 79: 1341\u20131352.","DOI":"10.1038\/ki.2010.536"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. <i>J Am Soc Nephrol<\/i> 2002; 13: 745\u2013753.","DOI":"10.1681\/ASN.V133745"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. <i>N Engl J Med<\/i> 2004; 351: 1296\u20131305.","DOI":"10.1056\/NEJMoa041031"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: A pooled analysis of community-based studies. <i>J Am Soc Nephrol<\/i> 2004; 15: 1307\u20131315.","DOI":"10.1097\/01.ASN.0000123691.46138.E2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, et al. Chronic kidney disease and cardiovascular risk: Epidemiology, mechanisms, and prevention. <i>Lancet<\/i> 2013; 382: 339\u2013352.","DOI":"10.1016\/S0140-6736(13)60595-4"},{"key":"9","unstructured":"9. Authors\/Task Force Members: Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention &amp; Rehabilitation (EACPR). <i>Eur J Prev Cardiol<\/i> 2016; 23: NP1\u2013NP96."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Al Suwaidi J, Reddan DN, Williams K, Pieper KS, Harrington RA, Califf RM, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. <i>Circulation<\/i> 2002; 106: 974\u2013980.","DOI":"10.1161\/01.CIR.0000027560.41358.B3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. S\u00f8rensen CR, Brendorp B, Rask-Madsen C, Kober L, Kjoller E, Torp-Pedersen C. The prognostic importance of creatinine clearance after acute myocardial infarction. <i>Eur Heart J<\/i> 2002; 23: 948\u2013952.","DOI":"10.1053\/euhj.2001.2989"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Wright RS, Reeder GS, Herzog CA, Albright RC, Williams BA, Dvorak DL, et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. <i>Ann Intern Med<\/i> 2002; 137: 563\u2013570.","DOI":"10.7326\/0003-4819-137-7-200210010-00007"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Pinero G, Avezum A, et al. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: Findings from the global registry of acute coronary events (GRACE). <i>Heart<\/i> 2003; 89: 1003\u20131008.","DOI":"10.1136\/heart.89.9.1003"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Halkin A, Singh M, Nikolsky E, Grines CL, Tcheng JE, Garcia E, et al. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: The CADILLAC risk score. <i>J Am Coll Cardiol<\/i> 2005; 45: 1397\u20131405.","DOI":"10.1016\/j.jacc.2005.01.041"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Lee JH, Park HS, Chae SC, Cho Y, Yang DH, Jeong MH, et al. Predictors of six-month major adverse cardiac events in 30-day survivors after acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). <i>Am J Cardiol<\/i> 2009; 104: 182\u2013189.","DOI":"10.1016\/j.amjcard.2009.03.010"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. <i>Circulation<\/i> 2006; 114: 774\u2013782.","DOI":"10.1161\/CIRCULATIONAHA.106.612812"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Granger CB, Goldberg RJ, Dabbous O, Pieper KS, Eagle KA, Cannon CP, et al. Predictors of hospital mortality in the global registry of acute coronary events. <i>Arch Intern Med<\/i> 2003; 163: 2345\u20132353.","DOI":"10.1001\/archinte.163.19.2345"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Subherwal S, Bach RG, Chen AY, Gage BF, Rao SV, Newby LK, et al. Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC\/AHA Guidelines) Bleeding Score. <i>Circulation<\/i> 2009; 119: 1873\u20131882.","DOI":"10.1161\/CIRCULATIONAHA.108.828541"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Kim HK, Jeong MH, Ahn Y, Kim JH, Chae SC, Kim YJ, et al. A new risk score system for the assessment of clinical outcomes in patients with non-ST-segment elevation myocardial infarction. <i>Int J Cardiol<\/i> 2010; 145: 450\u2013454.","DOI":"10.1016\/j.ijcard.2009.06.001"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, et al. Predictors of in-hospital mortality in patients hospitalized for heart failure: Insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). <i>J Am Coll Cardiol<\/i> 2008; 52: 347\u2013356.","DOI":"10.1016\/j.jacc.2008.04.028"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Wedel H, McMurray JJ, Lindberg M, Wikstrand J, Cleland JG, Cornel JH, et al. Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): Incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide. <i>Eur J Heart Fail<\/i> 2009; 11: 281\u2013291.","DOI":"10.1093\/eurjhf\/hfn046"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Senni M, Parrella P, De Maria R, Cottini C, Bohm M, Ponikowski P, et al. Predicting heart failure outcome from cardiac and comorbid conditions: The 3C-HF score. <i>Int J Cardiol<\/i> 2013; 163: 206\u2013211.","DOI":"10.1016\/j.ijcard.2011.10.071"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Pocock SJ, Ariti CA, McMurray JJ, Maggioni A, Kober L, Squire IB, et al. Predicting survival in heart failure: A risk score based on 39 372 patients from 30 studies. <i>Eur Heart J<\/i> 2013; 34: 1404\u20131413.","DOI":"10.1093\/eurheartj\/ehs337"},{"key":"24","unstructured":"24. Frankenstein L, Goode K, Ingle L, Remppis A, Schellberg D, Nelles M, et al. Derivation and validation of a simple clinical risk-model in heart failure based on 6 minute walk test performance and NT-proBNP status: Do we need specificity for sex and beta-blockers? <i>Int J Cardiol<\/i> 2011; 147: 74\u201378."},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Normand ST, Glickman ME, Sharma RG, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: Results from the Cooperative Cardiovascular Project. <i>JAMA<\/i> 1996; 275: 1322\u20131328.","DOI":"10.1001\/jama.1996.03530410036030"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV. Predicting mortality among patients hospitalized for heart failure: Derivation and validation of a clinical model. <i>JAMA<\/i> 2003; 290: 2581\u20132587.","DOI":"10.1001\/jama.290.19.2581"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ, Adhere Scientific Advisory Committee SG, et al. Risk stratification for in-hospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. <i>JAMA<\/i> 2005; 293: 572\u2013580.","DOI":"10.1001\/jama.293.5.572"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, et al. Serum urea nitrogen, creatinine, and estimators of renal function: Mortality in older patients with cardiovascular disease. <i>Arch Intern Med<\/i> 2006; 166: 1134\u20131142.","DOI":"10.1001\/archinte.166.10.1134"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Komajda M, Carson PE, Hetzel S, McKelvie R, McMurray J, Ptaszynska A, et al. Factors associated with outcome in heart failure with preserved ejection fraction: Findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE). <i>Circ Heart Fail<\/i> 2011; 4: 27\u201335.","DOI":"10.1161\/CIRCHEARTFAILURE.109.932996"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shiraishi J, Kohno Y, Nakamura T, Yanagiuchi T, Hashimoto S, Ito D, et al. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. <i>Int Heart J<\/i> 2014; 55: 301\u2013306.","DOI":"10.1536\/ihj.13-367"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. <i>N Engl J Med<\/i> 2004; 351: 1285\u20131295.","DOI":"10.1056\/NEJMoa041365"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Bohula EA, Bonaca MP, Braunwald E, Aylward PE, Corbalan R, De Ferrari GM, et al. Atherothrombotic risk stratification and the efficacy and safety of vorapaxar in patients with stable ischemic heart disease and previous myocardial infarction. <i>Circulation<\/i> 2016; 134: 304\u2013313.","DOI":"10.1161\/CIRCULATIONAHA.115.019861"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Hillege HL, Girbes AR, de Kam PJ, Boomsma F, de Zeeuw D, Charlesworth A, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. <i>Circulation<\/i> 2000; 102: 203\u2013210.","DOI":"10.1161\/01.CIR.102.2.203"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Hillege HL, Nitsch D, Pfeffer MA, Swedberg K, McMurray JJ, Yusuf S, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. <i>Circulation<\/i> 2006; 113: 671\u2013678.","DOI":"10.1161\/CIRCULATIONAHA.105.580506"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Postmus D, van Veldhuisen DJ, Jaarsma T, Luttik ML, Lassus J, Mebazaa A, et al. The COACH risk engine: A multistate model for predicting survival and hospitalization in patients with heart failure. <i>Eur J Heart Fail<\/i> 2012; 14: 168\u2013175.","DOI":"10.1093\/eurjhf\/hfr163"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Smith DH, Thorp ML, Gurwitz JH, McManus DD, Goldberg RJ, Allen LA, et al. Chronic kidney disease and outcomes in heart failure with preserved versus reduced ejection fraction: The Cardiovascular Research Network PRESERVE Study. <i>Circ Cardiovasc Qual Outcomes<\/i> 2013; 6: 333\u2013342.","DOI":"10.1161\/CIRCOUTCOMES.113.000221"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Inohara T, Kohsaka S, Sato N, Kajimoto K, Keida T, Mizuno M, et al. Prognostic impact of renal dysfunction does not differ according to the clinical profiles of patients: Insight from the acute decompensated heart failure syndromes (ATTEND) registry. <i>PLoS One<\/i> 2014; 9: e105596.","DOI":"10.1371\/journal.pone.0105596"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Uszko-Lencer NH, Frankenstein L, Spruit MA, Maeder MT, Gutmann M, Muzzarelli S, et al. Predicting hospitalization and mortality in patients with heart failure: The BARDICHE-index. <i>Int J Cardiol<\/i> 2017; 227: 901\u2013907.","DOI":"10.1016\/j.ijcard.2016.11.122"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Jacobs DR Jr, Kroenke C, Crow R, Deshpande M, Gu DF, Gatewood L, et al. PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: The Minnesota heart survey. <i>Circulation<\/i> 1999; 100: 599\u2013607.","DOI":"10.1161\/01.CIR.100.6.599"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. O\u2019Connor CM, Whellan DJ, Wojdyla D, Leifer E, Clare RM, Ellis SJ, et al. Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: The HF-ACTION predictive risk score model. <i>Circ Heart Fail<\/i> 2012; 5: 63\u201371.","DOI":"10.1161\/CIRCHEARTFAILURE.111.963462"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Peterson PN, Rumsfeld JS, Liang L, Albert NM, Hernandez AF, Peterson ED, et al. A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program. <i>Circ Cardiovasc Qual Outcomes<\/i> 2010; 3: 25\u201332.","DOI":"10.1161\/CIRCOUTCOMES.109.854877"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. O\u2019Connor CM, Hasselblad V, Mehta RH, Tasissa G, Califf RM, Fiuzat M, et al. Triage after hospitalization with advanced heart failure: The ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge score. <i>J Am Coll Cardiol<\/i> 2010; 55: 872\u2013878.","DOI":"10.1016\/j.jacc.2009.08.083"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Schiele F, Meneveau N, Chopard R, Descotes-Genon V, Oettinger J, Seronde MF, et al. Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction. <i>Am Heart J<\/i> 2009; 157: 327\u2013333.","DOI":"10.1016\/j.ahj.2008.09.018"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Miura M, Shiba N, Nochioka K, Takada T, Takahashi J, Kohno H, et al. Urinary albumin excretion in heart failure with preserved ejection fraction: An interim analysis of the CHART 2 study. <i>Eur J Heart Fail<\/i> 2012; 14: 367\u2013376.","DOI":"10.1093\/eurjhf\/hfs001"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Miura M, Sakata Y, Miyata S, Nochioka K, Takada T, Tadaki S, et al. Prognostic impact of subclinical microalbuminuria in patients with chronic heart failure. <i>Circ J<\/i> 2014; 78: 2890\u20132898.","DOI":"10.1253\/circj.CJ-14-0787"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. <i>Circulation<\/i> 2009; 120: 1577\u20131584.","DOI":"10.1161\/CIRCULATIONAHA.109.853648"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, et al. Albuminuria in chronic heart failure: Prevalence and prognostic importance. <i>Lancet<\/i> 2009; 374: 543\u2013550.","DOI":"10.1016\/S0140-6736(09)61378-7"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Masson S, Latini R, Milani V, Moretti L, Rossi MG, Carbonieri E, et al. Prevalence and prognostic value of elevated urinary albumin excretion in patients with chronic heart failure: Data from the GISSI-Heart Failure trial. <i>Circ Heart Fail<\/i> 2010; 3: 65\u201372.","DOI":"10.1161\/CIRCHEARTFAILURE.109.881805"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Nazer B, Ray KK, Murphy SA, Gibson CM, Cannon CP. Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: A PROVE IT-TIMI 22 substudy. <i>J Thromb Thrombolysis<\/i> 2013; 36: 233\u2013239.","DOI":"10.1007\/s11239-012-0853-0"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. \u00c5kerblom A, Clare RM, Lokhnygina Y, Wallentin L, Held C, Van de Werf F, et al. Albuminuria and cardiovascular events in patients with acute coronary syndromes: Results from the TRACER trial. <i>Am Heart J<\/i> 2016; 178: 1\u20138.","DOI":"10.1016\/j.ahj.2016.04.013"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics \u2013 2017 update: A report from the American Heart Association. <i>Circulation<\/i> 2017; 135: e146\u2013e603.","DOI":"10.1161\/CIR.0000000000000491"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Fox CS, Muntner P, Chen AY, Alexander KP, Roe MT, Cannon CP, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: A report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry. <i>Circulation<\/i> 2010; 121: 357\u2013365.","DOI":"10.1161\/CIRCULATIONAHA.109.865352"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Heywood JT, Fonarow GC, Costanzo MR, Mathur VS, Wigneswaran JR, Wynne J, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: A report from the ADHERE database. <i>J Card Fail<\/i> 2007; 13: 422\u2013430.","DOI":"10.1016\/j.cardfail.2007.03.011"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Edelmann F, Stahrenberg R, Gelbrich G, Durstewitz K, Angermann CE, Dungen HD, et al. Contribution of comorbidities to functional impairment is higher in heart failure with preserved than with reduced ejection fraction. <i>Clin Res Cardiol<\/i> 2011; 100: 755\u2013764.","DOI":"10.1007\/s00392-011-0305-4"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Kajimoto K, Sato N, Keida T, Sakata Y, Takano T; Acute Decompensated Heart Failure Syndromes (ATTEND) Investigators. Associations of anemia and renal dysfunction with outcomes among patients hospitalized for acute decompensated heart failure with preserved or reduced ejection fraction. <i>Clin J Am Soc Nephrol<\/i> 2014; 9: 1912\u20131921.","DOI":"10.2215\/CJN.04400514"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). <i>Am Heart J<\/i> 2005; 149: 209\u2013216.","DOI":"10.1016\/j.ahj.2004.08.005"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Lau JK, Anastasius MO, Hyun KK, Dabin B, Coverdale S, Ferry C, et al. Evidence-based care in a population with chronic kidney disease and acute coronary syndrome: Findings from the Australian Cooperative National Registry of Acute Coronary Care, Guideline Adherence and Clinical Events (CONCORDANCE). <i>Am Heart J<\/i> 2015; 170: 566\u2013572.e561.","DOI":"10.1016\/j.ahj.2015.06.025"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Gerber Y, Weston SA, Berardi C, McNallan SM, Jiang R, Redfield MM, et al. Contemporary trends in heart failure with reduced and preserved ejection fraction after myocardial infarction: A community study. <i>Am J Epidemiol<\/i> 2013; 178: 1272\u20131280.","DOI":"10.1093\/aje\/kwt109"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Klein L, Massie BM, Leimberger JD, O\u2019Connor CM, Pina IL, Adams KF Jr, et al. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: Results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). <i>Circ Heart Fail<\/i> 2008; 1: 25\u201333.","DOI":"10.1161\/CIRCHEARTFAILURE.107.746933"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Schrier RW. Blood urea nitrogen and serum creatinine: Not married in heart failure. <i>Circ Heart Fail<\/i> 2008; 1: 2\u20135.","DOI":"10.1161\/CIRCHEARTFAILURE.108.770834"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Shlipak MG, Matsushita K, Arnlov J, Inker LA, Katz R, Polkinghorne KR, et al. Cystatin C versus creatinine in determining risk based on kidney function. <i>N Engl J Med<\/i> 2013; 369: 932\u2013943.","DOI":"10.1056\/NEJMoa1214234"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Matsushita K, Sang Y, Ballew SH, Astor BC, Hoogeveen RC, Solomon SD, et al. Cardiac and kidney markers for cardiovascular prediction in individuals with chronic kidney disease: The Atherosclerosis Risk in Communities study. <i>Arterioscler Thromb Vasc Biol<\/i> 2014; 34: 1770\u20131777.","DOI":"10.1161\/ATVBAHA.114.303465"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: Ameta-analysis. <i>Am J Kidney Dis<\/i> 2002; 40: 221\u2013226.","DOI":"10.1053\/ajkd.2002.34487"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. <i>Clin Chem<\/i> 2005; 51: 321\u2013327.","DOI":"10.1373\/clinchem.2004.041889"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: Results from the studies of left ventricular dysfunction (SOLVD). <i>Am Heart J<\/i> 1999; 138: 849\u2013855.","DOI":"10.1016\/S0002-8703(99)70009-8"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. <i>Am Heart J<\/i> 1999; 138: 285\u2013290.","DOI":"10.1016\/S0002-8703(99)70113-4"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, Saucedo JF. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. <i>JACC Cardiovasc Interv<\/i> 2011; 4: 1002\u20131008.","DOI":"10.1016\/j.jcin.2011.05.022"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Wang HT, Chen YL, Wu CJ. Impact of chronic kidney disease on clinical outcomes in patients with non-ST elevation myocardial infarction receiving percutaneous coronary intervention: A five-year observational study. <i>Int J Cardiol<\/i> 2016; 220: 166\u2013172.","DOI":"10.1016\/j.ijcard.2016.06.184"},{"key":"69","unstructured":"69. McCullough PA. Cardiorenal risk: An important clinical intersection. <i>Rev Cardiovasc Med<\/i> 2002; 3: 71\u201376."},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Luft FC. Renal disease as a risk factor for cardiovascular disease. <i>Basic Res Cardiol<\/i> 2000; 95(Suppl 1): I72\u2013I76.","DOI":"10.1007\/s003950070013"},{"key":"71","unstructured":"71. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. <i>J Am Soc Nephrol<\/i> 1998; 9: S16\u2013S23."},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. <i>J Am Coll Cardiol<\/i> 2008; 52: 1527\u20131539.","DOI":"10.1016\/j.jacc.2008.07.051"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Ronco C, Di Lullo L. Cardiorenal syndrome. <i>Heart Fail Clin<\/i> 2014; 10: 251\u2013280.","DOI":"10.1016\/j.hfc.2013.12.003"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Hruska KA, Seifert M, Sugatani T. Pathophysiology of the chronic kidney disease \u2013 mineral bone disorder. <i>Curr Opin Nephrol Hypertens<\/i> 2015; 24: 303\u2013309.","DOI":"10.1097\/MNH.0000000000000132"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Moradi H, Sica DA, Kalantar-Zadeh K. Cardiovascular burden associated with uremic toxins in patients with chronic kidney disease. <i>Am J Nephrol<\/i> 2013; 38: 136\u2013148.","DOI":"10.1159\/000351758"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Ross R. Atherosclerosis: An inflammatory disease. <i>N Engl J Med<\/i> 1999; 340: 115\u2013126.","DOI":"10.1056\/NEJM199901143400207"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. <i>Diabetes Care<\/i> 1999; 22: 1865\u20131870.","DOI":"10.2337\/diacare.22.11.1865"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Pedrinelli R, Giampietro O, Carmassi F, Melillo E, Dell\u2019Omo G, Catapano G, et al. Microalbuminuria and endothelial dysfunction in essential hypertension. <i>Lancet<\/i> 1994; 344: 14\u201318.","DOI":"10.1016\/S0140-6736(94)91047-2"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Paulus WJ, Tschope C. A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. <i>J Am Coll Cardiol<\/i> 2013; 62: 263\u2013271.","DOI":"10.1016\/j.jacc.2013.02.092"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Attallah N, Yassine L, Fisher K, Yee J. Risk of bleeding and restenosis among chronic kidney disease patients undergoing percutaneous coronary intervention. <i>Clin Nephrol<\/i> 2005; 64: 412\u2013418.","DOI":"10.5414\/CNP64412"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Szczech LA, Best PJ, Crowley E, Brooks MM, Berger PB, Bittner V, et al. Outcomes of patients with chronic renal insufficiency in the bypass angioplasty revascularization investigation. <i>Circulation<\/i> 2002; 105: 2253\u20132258.","DOI":"10.1161\/01.CIR.0000016051.33225.33"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Fox KA, Antman EM, Montalescot G, Agewall S, SomaRaju B, Verheugt FW, et al. The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial. <i>J Am Coll Cardiol<\/i> 2007; 49: 2249\u20132255.","DOI":"10.1016\/j.jacc.2006.12.049"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Keltai M, Tonelli M, Mann JF, Sitkei E, Lewis BS, Hawken S, et al. Renal function and outcomes in acute coronary syndrome: Impact of clopidogrel. <i>Eur J Cardiovasc Prev Rehabil<\/i> 2007; 14: 312\u2013318.","DOI":"10.1097\/01.hjr.0000220582.19516.a6"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Alexander KP, Chen AY, Roe MT, Newby LK, Gibson CM, Allen-LaPointe NM, et al. Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes. <i>JAMA<\/i> 2005; 294: 3108\u20133116.","DOI":"10.1001\/jama.294.24.3108"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Medi C, Chew DP, Amerena J, Coverdale S, Soman A, Astley C, et al. An invasive management strategy is associated with improved outcomes in high-risk acute coronary syndromes in patients with chronic kidney disease. <i>Intern Med J<\/i> 2011; 41: 743\u2013750.","DOI":"10.1111\/j.1445-5994.2010.02361.x"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: Data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). <i>Circulation<\/i> 2009; 120: 851\u2013858.","DOI":"10.1161\/CIRCULATIONAHA.108.838169"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Abe D, Sato A, Hoshi T, Kakefuda Y, Watabe H, Ojima E, et al. Clinical predictors of contrast-induced acute kidney injury in patients undergoing emergency versus elective percutaneous coronary intervention. <i>Circ J<\/i> 2014; 78: 85\u201391.","DOI":"10.1253\/circj.CJ-13-0574"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Chong E, Poh KK, Liang S, Soon CY, Tan HC. Comparison of risks and clinical predictors of contrast-induced nephropathy in patients undergoing emergency versus nonemergency percutaneous coronary interventions. <i>J Interv Cardiol<\/i> 2010; 23: 451\u2013459.","DOI":"10.1111\/j.1540-8183.2010.00581.x"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Charytan D, Kuntz RE. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. <i>Kidney Int<\/i> 2006; 70: 2021\u20132030.","DOI":"10.1038\/sj.ki.5001934"},{"key":"90","unstructured":"90. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure: The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. <i>Lancet<\/i> 1993; 342: 821\u2013828."},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ Jr, Cuddy TE, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the survival and ventricular enlargement trial: Results of the survival and ventricular enlargement trial: The SAVE Investigators. <i>N Engl J Med<\/i> 1992; 327: 669\u2013677.","DOI":"10.1056\/NEJM199209033271001"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Swedberg K, Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). <i>Am J Cardiol<\/i> 1988; 62: 60A\u201366A.","DOI":"10.1016\/S0002-9149(88)80087-0"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Evans M, Carrero JJ, Szummer K, \u00c5kerblom A, Edfors R, Spaak J, et al. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in myocardial infarction patients with renal dysfunction. <i>J Am Coll Cardiol<\/i> 2016; 67: 1687\u20131697.","DOI":"10.1016\/j.jacc.2016.01.050"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Beygui F, Cayla G, Roule V, Roubille F, Delarche N, Silvain J, et al. Early aldosterone blockade in acute myocardial infarction: The ALBATROSS randomized clinical trial. <i>J Am Coll Cardiol<\/i> 2016; 67: 1917\u20131927.","DOI":"10.1016\/j.jacc.2016.02.033"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Savarese G, Edner M, Dahlstrom U, Perrone-Filardi P, Hage C, Cosentino F, et al. Comparative associations between angiotensin converting enzyme inhibitors, angiotensin receptor blockers and their combination, and outcomes in patients with heart failure and reduced ejection fraction. <i>Int J Cardiol<\/i> 2015; 199: 415\u2013423.","DOI":"10.1016\/j.ijcard.2015.07.051"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina\/non-ST elevation MI: A method for prognostication and therapeutic decision making. <i>JAMA<\/i> 2000; 284: 835\u2013842.","DOI":"10.1001\/jama.284.7.835"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Addala S, Grines CL, Dixon SR, Stone GW, Boura JA, Ochoa AB, et al. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score). <i>Am J Cardiol<\/i> 2004; 93: 629\u2013632.","DOI":"10.1016\/j.amjcard.2003.11.036"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. De Luca G, Suryapranata H, van\u2019t Hof AW, de Boer MJ, Hoorntje JC, Dambrink JH, et al. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: Implications for early discharge. <i>Circulation<\/i> 2004; 109: 2737\u20132743.","DOI":"10.1161\/01.CIR.0000131765.73959.87"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Karam N, Bataille S, Marijon E, Giovanetti O, Tafflet M, Savary D, et al. Identifying patients at risk for pre-hospital sudden cardiac arrest at the early phase of myocardial infarction: The e-MUST study. <i>Circulation<\/i> 2016; 134: 2074\u20132083.","DOI":"10.1161\/CIRCULATIONAHA.116.022954"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. Berton G, Cordiano R, Palmieri R, Cavuto F, Buttazzi P, Palatini P. Comparison of C-reactive protein and albumin excretion as prognostic markers for 10-year mortality after myocardial infarction. <i>Clin Cardiol<\/i> 2010; 33: 508\u2013515.","DOI":"10.1002\/clc.20792"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB, et al. The Seattle Heart Failure Model: Prediction of survival in heart failure. <i>Circulation<\/i> 2006; 113: 1424\u20131433.","DOI":"10.1161\/CIRCULATIONAHA.105.584102"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, et al. Predictors of mortality and morbidity in patients with chronic heart failure. <i>Eur Heart J<\/i> 2006; 27: 65\u201375.","DOI":"10.1093\/eurheartj\/ehi555"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. American Diabetes A. 8: Cardiovascular disease and risk management. <i>Diabetes Care<\/i> 2016; 39(Suppl 1): S60\u2013S71.","DOI":"10.2337\/dc16-S011"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). <i>JAMA<\/i> 2014; 311: 507\u2013520.","DOI":"10.1001\/jama.2013.284427"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Kjekshus J, Apetrei E, Barrios V, B\u00f6hm M, Cleland JGF, Cornel JH, et al. Rosuvastatin in older patients with systolic heart failure. <i>N Engl J Med<\/i> 2007; 357: 2248\u20132261.","DOI":"10.1056\/NEJMoa0706201"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/8\/81_CJ-17-0550\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T13:49:05Z","timestamp":1659188945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/81\/8\/81_CJ-17-0550\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-17-0550","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}